Psychopathology
Original Paper
Amplification and Attribution Styles in Somatoform and Depressive Disorders – A Study from Bangalore, IndiaDuddu V. · Chaturvedi S.K. · Isaac M.K.National Institute of Mental Health and Neurosciences, Bangalore, India
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: May 23, 2003
Issue release date: March – April
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3
ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)
For additional information: https://www.karger.com/PSP
Abstract
Objective: The present investigation aimed to study attribution styles and somatosensory amplification among patients suffering from somatoform and depressive disorders. Methods: Two groups of 30 patients with diagnoses of somatoform disorder and depressive disorder, respectively (ICD-10 DCR), and one group of 30 normal controls were recruited. The study patients were assessed using the symptom interpretation questionnaire, somatosensory amplification scale, and scales for assessing alexithymia and illness attitudes. Results: The somatoform and depressive disorder patients had greater recent symptom experience than the normal group. The somatoform disorder group had higher somatic attribution scores, the depressive disorder sample had higher psychological attribution scores, and the normal group had higher normalizing attribution scores than the two other groups. Somatoform disorder patients had higher mean amplification scores than depressed patients, who in turn had higher scores than normals. Correlation analyses showed somatic attribution and certain illness attitudes to be closely associated in all three groups. Recent symptom experience was associated with amplification in the somatoform disorder group alone. Recent symptom experience, a diagnosis of somatoform disorder and lower normalizing attribution scores predicted amplification. Discussion: These findings indicate that somatoform and depressive disorder patients and normals differ from each other in their attribution styles. There is a clustering of attributes among somatoform disorder patients that include greater symptom experience, which is somatically attributed, and is associated with excessive illness worry, concern and preoccupation with bodily symptoms, and a fear of having or developing a disease. On the other hand, depressed patients and normal subjects who do have a somatic attribution style (though, as a group, they have lower somatic attribution scores than the somatoform disorder group), also harbor hypochondriacal beliefs and related attitudes.
© 2003 S. Karger AG, Basel
Related Articles:
References
- Katon W, Kleinman A, Rosen G: Depression and somatization – A review. Part 1. Am J Med 1982;72:127–135.
- Bridges KW, Goldberg DP: Somatic presentation of DSM-III psychiatric disorders in primary care. J Psychosom Res 1985;29:563–569.
-
Lipowsky ZJ: Somatization: The concept and its clinical application. Am J Psychiatry 1988;345:1358–1368.
- Spinhoven P, van der Does AJ: Somatization and somatosensory amplification in psychiatric outpatients: An exploratory study. Compr Psychiatry 1997;38:93–97.
- Barsky AJ: Amplification, somatization and somatoform disorders. Psychosomatics 1992;33:28–34.
- Barsky AJ, Klerman GL: Overview: Hypochondriasis, bodily complaints and somatic styles. Am J Psychiatry 1983;140:273–283.
- Barsky AJ: Patients who amplify bodily sensations. Ann Intern Med 1979;91:63–70.
- Robbins JM, Kirmayer LJ: Attributions of common somatic symptoms. Psychol Med 1991;21:1029–1045.
-
Kirmayer LJ: Culture, affect and somatization. Transcult Psychiatry Res Rev 1984;21:159–188, 237–262.
-
World Health Organization: ICD-10 Classification of Mental/Behavioral Disorders. WHO, Geneva, 1992.
-
World Health Organization: Schedules for Clinical Assessments in Neuropsychiatry, version 2.0. WHO, Geneva, 1992.
- Goldberg DP, Hillier VF: A scaled version of the General Health Questionnaire. Psychol Med 1979;9:139–145.
- Barsky AJ, Wyshak G, Klerman GC: The Somatosensory Amplification Scale and its relationship to hypochondriasis. J Psychiatr Res 1990;24:323–334.
- Taylor GJ, Bagby RM, Ryan DP, Parker JDA, Doody KF, Keefe P: Criterion validity of the Toronto Alexithymia Scale. Psychosom Med 1988;50:500–509.
- Kellner R, Abbott P, Winslow WW, Pathak D: Fears, beliefs and attitudes in DSM-III hypochondriasis. J Nerv Ment Dis 1987;175:20–25.
- Wise TN, Mann LS: The attribution of somatic symptoms in psychiatric outpatients. Compr Psychiatry 1995;36:407–410.
- Barsky AJ, Goodson JD, Lane RS, Cleary PD: The amplification of somatic symptoms. Psychosom Med 1988;50:510–519.
Article / Publication Details
Published online: May 23, 2003
Issue release date: March – April
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3
ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)
For additional information: https://www.karger.com/PSP
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
